ORAGENICS INC (31)
Browse by Contract Category
Contracts
-
Executive Employment Agreement for Ms. Huffman dated effective March 7, 2023
(Filed With SEC on March 8, 2023)
-
At the Market Offering Agreement dated February 24, 2023, by and among Oragenics, Inc. and Ladenburg Thalmann & Co. Inc
(Filed With SEC on February 24, 2023)
-
Specimen Stock Certificate
(Filed With SEC on January 23, 2023)
-
NRC Technology License Amendment 4
(Filed With SEC on August 9, 2022)
-
Amended and Restated Exclusive Channel Collaboration Agreement by and between Oragenics, Inc. and Eleszto Genetika, Inc. dated as of March 1, 2021(Lantibiotic ECC)
(Filed With SEC on March 1, 2021)
-
Second Amendment to Lease Agreement between the Company and Hawley-Wiggins LLC dated July 13, 2014 (13700 Progress Blvd, Alachua, FL 32615)
(Filed With SEC on March 4, 2020)
-
Executive Employment Agreement for Ms. Murphy dated June 23, 2022
(Filed With SEC on June 23, 2022)
-
NRC Technology License Amendment 3
(Filed With SEC on March 24, 2022)
-
NRC Technology License Amendment 2
(Filed With SEC on March 24, 2022)
-
Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
(Filed With SEC on March 24, 2022)
-
Form Stock Option Award Agreement (Consultants)
(Filed With SEC on February 28, 2022)
-
Form Stock Option Award Agreement (Employees)
(Filed With SEC on February 28, 2022)
-
Form Stock Option Award Agreement (Directors)
(Filed With SEC on February 28, 2022)
-
2021 Equity Incentive Plan
(Filed With SEC on February 28, 2022)
-
Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act Of 1934
(Filed With SEC on March 1, 2021)
-
Sales Agent Agreement dated February 1, 2021
(Filed With SEC on February 1, 2021)
-
Form of Securities Purchase Agreement
(Filed With SEC on December 28, 2020)
-
Placement Agent Agreement dated December 23, 2020
(Filed With SEC on December 28, 2020)
-
Underwriting Agreement dated November 19, 2020
(Filed With SEC on November 24, 2020)
-
Non-exclusive intellectual property and biological materials license agreement with the National Institute of Allergy and Infectious Diseases, an institute within the National...
(Filed With SEC on August 14, 2020)
-
Second Amendment to Employment Agreement between the Company and Alan Joslyn effective June 6, 2020
(Filed With SEC on June 5, 2020)
-
Stock Purchase Agreement, dated May 1, 2020
(Filed With SEC on May 4, 2020)
-
Warrant, dated May 1, 2020
(Filed With SEC on May 4, 2020)
-
Form of Notice of Grant of Stock Options and Stock Option Award Agreement (Directors)
(Filed With SEC on March 4, 2020)
-
Notice of Assignment of Lantibiotic ECC and Lantibiotic SIA by and between Oragenics, Inc. and Intrexon Corporation (n/k/a Precigen Inc.) to ILH Holdings Inc. effective January 1,...
(Filed With SEC on March 4, 2020)
-
Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act Of 1934
(Filed With SEC on March 4, 2020)
-
Fourth Amendment to 2012 Equity Incentive Plan
(Filed With SEC on June 21, 2019)
-
Specimen Stock Certificate
(Filed With SEC on March 29, 2019)
-
Underwriting Agreement dated March 21, 2019
(Filed With SEC on March 25, 2019)
-
Form of Series 2 Warrant
(Filed With SEC on March 25, 2019)
-
Form of Series 1 Warrant
(Filed With SEC on March 25, 2019)